Cornell’s Research
Serves the Region and Beyond

A Cornell Business and Technology Park Company

OptiGen, LLC CTL

Veterinary Testing Laboratory

  • Products:
  • Genetic testing service for many canine breeds

OptiGen, LLC is a private genetic service company that provides testing for inherited diseases of dogs, serving dog owners, breeders, and their veterinarians. The company’s tests determine the genetic status for various mutations, with special focus on multiple forms of progressive retinal atrophy, day blindness, and other inherited diseases of the eye. The company’s goal is to implement tests for additional types of inherited diseases as well as to promote discovery of new disease-causing mutations in dogs through internal and collaborative research programs.

OptiGen, LLC was acquired by Mars Petcare in April of 2018.

Cornell Connection

The initial testing services of OptiGen were based on the discoveries made by faculty members of Cornell’s Baker Institute for Animal Health. The company’s core tests for eye diseases in purebred dogs were developed at Cornell. The company uses licensed Cornell technology and continues to pursue research interactions with the university.